Potential cytokine biomarkers in autism spectrum disorders

Destanie Rose, Paul Ashwood

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Autism spectrum disorders (ASD) are complex neurodevelopmental disorders characterized by impairments in three core behavioral areas. As prevalence rates for ASD continue to rise there is also increasing interest in finding biomarkers associated with ASD. The use of biomarkers could help identify those at risk for ASD or ASD-associated comorbid conditions and help to predict the developmental course of these children. Due to the heterogeneity of ASD, biomarkers may help to identify subpopulations within ASD that share similar traits or profiles. Such work could lead to specialized therapy and help to develop biomarkers whereby the benefits of treatments/therapies for individuals could be monitored over time and through clinical trials. Over the last 10 years, the evidence of immune involvement in ASD has been steadily growing and many investigators have begun to look at possible immune biomarkers, such as immune cytokine profiles, in children with ASD.

Original languageEnglish (US)
Pages (from-to)1171-1181
Number of pages11
JournalBiomarkers in Medicine
Volume8
Issue number9
DOIs
StatePublished - Oct 1 2014

Fingerprint

Biomarkers
Cytokines
Autism Spectrum Disorder
Therapeutics
Research Personnel
Clinical Trials

Keywords

  • Autism spectrum disorders
  • Biomarkers
  • Chemokines
  • Cytokines
  • Immune system
  • Maternal immune system

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Potential cytokine biomarkers in autism spectrum disorders. / Rose, Destanie; Ashwood, Paul.

In: Biomarkers in Medicine, Vol. 8, No. 9, 01.10.2014, p. 1171-1181.

Research output: Contribution to journalArticle

@article{95a8d363f15745ca973f5bc93ac07fd4,
title = "Potential cytokine biomarkers in autism spectrum disorders",
abstract = "Autism spectrum disorders (ASD) are complex neurodevelopmental disorders characterized by impairments in three core behavioral areas. As prevalence rates for ASD continue to rise there is also increasing interest in finding biomarkers associated with ASD. The use of biomarkers could help identify those at risk for ASD or ASD-associated comorbid conditions and help to predict the developmental course of these children. Due to the heterogeneity of ASD, biomarkers may help to identify subpopulations within ASD that share similar traits or profiles. Such work could lead to specialized therapy and help to develop biomarkers whereby the benefits of treatments/therapies for individuals could be monitored over time and through clinical trials. Over the last 10 years, the evidence of immune involvement in ASD has been steadily growing and many investigators have begun to look at possible immune biomarkers, such as immune cytokine profiles, in children with ASD.",
keywords = "Autism spectrum disorders, Biomarkers, Chemokines, Cytokines, Immune system, Maternal immune system",
author = "Destanie Rose and Paul Ashwood",
year = "2014",
month = "10",
day = "1",
doi = "10.2217/BMM.14.39",
language = "English (US)",
volume = "8",
pages = "1171--1181",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Potential cytokine biomarkers in autism spectrum disorders

AU - Rose, Destanie

AU - Ashwood, Paul

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Autism spectrum disorders (ASD) are complex neurodevelopmental disorders characterized by impairments in three core behavioral areas. As prevalence rates for ASD continue to rise there is also increasing interest in finding biomarkers associated with ASD. The use of biomarkers could help identify those at risk for ASD or ASD-associated comorbid conditions and help to predict the developmental course of these children. Due to the heterogeneity of ASD, biomarkers may help to identify subpopulations within ASD that share similar traits or profiles. Such work could lead to specialized therapy and help to develop biomarkers whereby the benefits of treatments/therapies for individuals could be monitored over time and through clinical trials. Over the last 10 years, the evidence of immune involvement in ASD has been steadily growing and many investigators have begun to look at possible immune biomarkers, such as immune cytokine profiles, in children with ASD.

AB - Autism spectrum disorders (ASD) are complex neurodevelopmental disorders characterized by impairments in three core behavioral areas. As prevalence rates for ASD continue to rise there is also increasing interest in finding biomarkers associated with ASD. The use of biomarkers could help identify those at risk for ASD or ASD-associated comorbid conditions and help to predict the developmental course of these children. Due to the heterogeneity of ASD, biomarkers may help to identify subpopulations within ASD that share similar traits or profiles. Such work could lead to specialized therapy and help to develop biomarkers whereby the benefits of treatments/therapies for individuals could be monitored over time and through clinical trials. Over the last 10 years, the evidence of immune involvement in ASD has been steadily growing and many investigators have begun to look at possible immune biomarkers, such as immune cytokine profiles, in children with ASD.

KW - Autism spectrum disorders

KW - Biomarkers

KW - Chemokines

KW - Cytokines

KW - Immune system

KW - Maternal immune system

UR - http://www.scopus.com/inward/record.url?scp=84911462588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911462588&partnerID=8YFLogxK

U2 - 10.2217/BMM.14.39

DO - 10.2217/BMM.14.39

M3 - Article

C2 - 25402586

AN - SCOPUS:84911462588

VL - 8

SP - 1171

EP - 1181

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 9

ER -